What this deck covers
This deck focuses on Self Monitoring And Administration Devices, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Self Monitoring And Administration Devices in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
Which hematocrit-related condition can cause inaccurate SMBG readings?
Tap card or press Space to flip
Extremes of hematocrit (anemia or polycythemia). High or low hematocrit alters blood viscosity, interfering with the meter's enzymatic reaction and glucose detection.
How well did you know it?
Card 1 / 25
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Self Monitoring And Administration Devices, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: Extremes of hematocrit (anemia or polycythemia). High or low hematocrit alters blood viscosity, interfering with the meter's enzymatic reaction and glucose detection.
Answer: Clean/dry site → lance → apply blood to strip → read result. This sequence ensures hygienic sampling, proper blood application, and accurate meter interpretation for reliable results.
Answer: Prime with 2 units (or per product labeling) until a drop appears. Priming expels air bubbles and ensures the needle is clear, guaranteeing full and accurate dose delivery.
Answer: Keep strips sealed, dry, and at room temperature. These conditions protect enzymes on strips from moisture, heat, and air, maintaining their reactivity and accuracy.
Answer: Lateral side of the fingertip. This site minimizes pain and callus formation while providing adequate blood flow for accurate sampling.
Answer: Acetaminophen may falsely elevate readings on some CGMs. Acetaminophen interferes with the sensor's electrochemical signal in certain systems, leading to overestimated glucose levels.
Answer: Trend data and hypoglycemia alerts with time-in-range assessment. CGM provides continuous insights and proactive alerts, enabling better glycemic control through time-in-range metrics.
Answer: Use a new lancet and avoid the fingertip pad/center. Fresh lancets prevent infection and dullness, while avoiding the pad reduces nerve irritation and long-term damage.
Answer: Multiple daily injections. This abbreviation refers to a regimen involving several insulin doses per day to mimic physiologic insulin secretion.
Answer: Avoid that area; absorption is unpredictable and dosing may be unreliable. Lipohypertrophied tissue alters insulin pharmacokinetics, so avoidance ensures predictable dosing and glycemic response.
Answer: Rotate within the same anatomic area to reduce lipohypertrophy. Systematic rotation within areas maintains consistent absorption and prevents tissue buildup from repeated trauma.
Answer: Percent of time glucose is 70–180 mg/dL. This metric quantifies glycemic stability within the target range, guiding therapy adjustments for optimal diabetes control.
Answer: Insulin pen. Pens allow precise dosing via a dial mechanism, improving convenience and accuracy over traditional syringes.
Answer: CGM measures interstitial glucose with a time lag vs blood glucose. Interstitial fluid glucose trails blood glucose by 5-15 minutes due to diffusion time, causing temporary discrepancies.
Answer: Self-monitoring of blood glucose. This acronym denotes the patient-led process of regularly assessing blood sugar levels to manage diabetes effectively.
Answer: Continuous glucose monitoring. This term describes real-time tracking of glucose levels using subcutaneous sensors for ongoing diabetes management.
Answer: Glucose contamination on fingers (not washing hands). Residual glucose from food or products on unwashed hands can contaminate the sample, inflating the measured value.
Answer: Lipohypertrophy. Repeated injections cause fat tissue hypertrophy, leading to hardened areas that impair insulin absorption.
Answer: Draw up clear (regular) before cloudy (NPH): "clear to cloudy". This order prevents NPH particles from contaminating the clear insulin vial, preserving purity and stability.
Answer: Abdomen (avoid 2 inches around the navel). The abdomen offers rapid absorption due to high vascularity, but avoiding the navel prevents inconsistent uptake from scar tissue.
Answer: Verify meter and strip performance within control range. Control solutions confirm the meter's calibration and strip functionality, ensuring readings fall within expected ranges.
Answer: Rapidly rising or falling trend arrows with symptoms or alerts. Trend arrows indicate dynamic changes where CGM lag may amplify errors, necessitating blood confirmation for safe dosing.
Answer: New meter/strips, after drops, or when results do not match symptoms. Testing at these times detects potential malfunctions or degradation, safeguarding the reliability of glucose measurements.
Answer: Wash with soap and water and dry completely. Proper cleaning removes contaminants that could skew glucose readings, ensuring sample integrity for accurate testing.
Answer: Rapidly changing glucose (post-meal, post-exercise, or after insulin). Alternate sites like the forearm or thigh exhibit a lag in glucose changes, leading to discrepancies during rapid fluctuations.